These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25524408)

  • 21. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
    Classey JD; Bartsch T; Goadsby PJ
    Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of calcitonin gene-related peptide in trigeminal ganglion following chronic exposure to paracetamol in a CSD migraine animal model.
    Yisarakun W; Chantong C; Supornsilpchai W; Thongtan T; Srikiatkhachorn A; Reuangwechvorachai P; Maneesri-le Grand S
    Neuropeptides; 2015 Jun; 51():9-16. PubMed ID: 25998753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
    Williamson DJ; Shepheard SL; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1997 Jun; 328(1):61-4. PubMed ID: 9203569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rizatriptan benzoate influences the endogenous pain modulatory system in a rat model of migraine.
    Yao G; Man Y; Luo X; Yu T; Ji L
    Neural Regen Res; 2012 Jan; 7(2):131-5. PubMed ID: 25767488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
    MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2004; 44(7):669-73. PubMed ID: 15209688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception.
    Bartsch T; Knight YE; Goadsby PJ
    Ann Neurol; 2004 Sep; 56(3):371-81. PubMed ID: 15349864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of 5-HT1B/1D receptors in the inflammatory response and oxidative stress in intestinal ischemia/reperfusion in rats.
    Gharishvandi F; Abdollahi A; Shafaroodi H; Mohammad Jafari R; Pasalar P; Dehpour AR
    Eur J Pharmacol; 2020 Sep; 882():173265. PubMed ID: 32574671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptans and CGRP blockade - impact on the cranial vasculature.
    Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Vollesen AL; Lampl C; Ashina M;
    J Headache Pain; 2017 Oct; 18(1):103. PubMed ID: 29019093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan.
    Goadsby PJ; Hargreaves RJ
    Neurology; 2000; 55(9 Suppl 2):S8-14. PubMed ID: 11089513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical study of cholecystokinin peptide in rat spinal motoneurons.
    Cortés R; Aman K; Arvidsson U; Terenius L; Frey P; Rehfeld JF; Walsh JH; Hökfelt T
    Synapse; 1991 Oct; 9(2):103-10. PubMed ID: 1726545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitroglycerin facilitates calcitonin gene-related peptide-induced behavior.
    Yao D; Sessle BJ
    Neuroreport; 2008 Aug; 19(13):1307-11. PubMed ID: 18695513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
    Ho TW; Rodgers A; Bigal ME
    Headache; 2009 Mar; 49(3):395-403. PubMed ID: 19222588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
    Ng-Mak DS; Hu XH; Chen Y; Ma L; Solomon G
    Int J Clin Pract; 2007 Jul; 61(7):1091-111. PubMed ID: 17537184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks.
    Müller T; Lohse L
    Clin Neuropharmacol; 2011; 34(6):206-9. PubMed ID: 21996647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinociceptive effects of calcitonin gene-related peptide injected into periaqueductal grey of rats with mononeuropathy.
    Xu S; Lundeberg T; Yu L
    Brain Res; 2000 Mar; 859(2):358-60. PubMed ID: 10719085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.